Elizabeth A. McGraw

Elizabeth A. McGraw

Auto-generated profile, based on publicly available information

Elizabeth A. McGraw

Affiliations Department of Biology, The Pennsylvania State University, University Park, Pennsylvania, United States of America, The Huck Institutes of the Life Sciences, The Pennsylvania State University, University Park, Pennsylvania, United States of America

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2013 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
ECEric P. Caragata
Eric P. Caragata
EREdwige Rancès
Edwige Rancès
LHLauren M. Hedges
Lauren M. Hedges
AGAlexander William Gofton
Alexander William Gofton
Karyn JohnsonKaryn Johnson
Karyn Johnson
EMElizabeth A. McGraw
Elizabeth A. McGraw
The bacterial endosymbiont Wolbachia pipientis protects its hosts from a range of pathogens by limiting their ability to form infections inside the insect. This “pathogen blocking” could be explained by innate immune priming by the symbiont, competition for host-derived resources between pathogens and Wolbachia, or the direct modification of the cell or cellular environment by Wolbachia. Recent comparative work in Drosophila and the mosquito Aedes aegypti has shown that an immune response is not required for pathogen blocking, implying that there must be an additional component to the mechanism. Here we have examined the involvement of cholesterol in pathogen blocking using a system of dietary manipulation in Drosophila melanogaster in combination with challenge by Drosophila C virus (DCV), a common fly pathogen. We observed that flies reared on cholesterol-enriched diets infected with the Wolbachia strains wMelPop and wMelCS exhibited reduced pathogen blocking, with viral-induced mortality occurring 2–5 days earlier than flies reared on Standard diet. This shift toward greater virulence in the presence of cholesterol also corresponded to higher viral copy numbers in the host. Interestingly, an increase in dietary cholesterol did not have an effect on Wolbachia density except in one case, but this did not directly affect the strength of pathogen blocking. Our results indicate that host cholesterol levels are involved with the ability of Wolbachia-infected flies to resist DCV infections, suggesting that cholesterol contributes to the underlying mechanism of pathogen blocking. Wolbachia pipientis is an intracellular bacterium that naturally infects many insect species. These bacteria can block the replication and dissemination of a variety of pathogens that coinfect the insect. In mosquitoes this effect applies to viruses including dengue and the parasite that causes malaria. This makes Wolbachia a promising method of controlling a number of insect-transmitted diseases of humans. Some studies suggest that pathogen blocking is due to Wolbachia stimulating the host innate immune system, however in the fly Drosophila melanogaster, blocking occurs in the absence of such an immune effect. This suggests that there is an additional component to the mechanism. Host nutrients such as cholesterol are a limiting factor in virus replication and may serve as a source of competition that underlies pathogen blocking. Here we show that competition over cholesterol contributes to the pathogen blocking effect, with higher available cholesterol levels causing less effective blocking, and increased viral titres in Wolbachia-infected D. melanogaster challenged with the pathogenic Drosophila C virus. These results suggest that competition over cholesterol is an important part of the pathogen blocking mechanism.

13 December 2013 in Microbial Ecology
Verified
Journal Article
Closed access
PDF file
ECEric P. Caragata
Eric P. Caragata
EREdwige Rancès
Edwige Rancès
SOScott L. O’nEill
Scott L. O’nEill
EMElizabeth A. McGraw
Elizabeth A. McGraw

26 June 2015 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
YYYixin H Ye
Yixin H Ye
ACAlison M Carrasco
Alison M Carrasco
FFFrancesca Frentiu
Francesca Frentiu
SCStephen F Chenoweth
Stephen F Chenoweth
NBNigel W Beebe
Nigel W Beebe
EMElizabeth A McGraw
Elizabeth A McGraw
Dengue viruses (DENV) are the causative agents of dengue, the world’s most prevalent arthropod-borne disease with around 40% of the world’s population at risk of infection annually. Wolbachia pipientis, an obligate intracellular bacterium, is being developed as a biocontrol strategy against dengue because it limits replication of the virus in the mosquito. The Wolbachia strain wMel, which has been introduced into the mosquito vector, Aedes aegypti, has been shown to invade and spread to near fixation in field releases. Standard measures of Wolbachia’s efficacy for blocking virus replication focus on the detection and quantification of virus in mosquito tissues. Examining the saliva provides a more accurate measure of transmission potential and can reveal the extrinsic incubation period (EIP), that is, the time it takes virus to arrive in the saliva following the consumption of DENV viremic blood. EIP is a key determinant of a mosquito’s ability to transmit DENVs, as the earlier the virus appears in the saliva the more opportunities the mosquito will have to infect humans on subsequent bites. We used a non-destructive assay to repeatedly quantify DENV in saliva from wMel-infected and Wolbachia-free wild-type control mosquitoes following the consumption of a DENV-infected blood meal. We show that wMel lengthens the EIP, reduces the frequency at which the virus is expectorated and decreases the dengue copy number in mosquito saliva as compared to wild-type mosquitoes. These observations can at least be partially explained by an overall reduction in saliva produced by wMel mosquitoes. More generally, we found that the concentration of DENV in a blood meal is a determinant of the length of EIP, saliva virus titer and mosquito survival. The saliva-based traits reported here offer more disease-relevant measures of Wolbachia’s effects on the vector and the virus. The lengthening of EIP highlights another means, in addition to the reduction of infection frequencies and DENV titers in mosquitoes, by which Wolbachia should operate to reduce DENV transmission in the field. Dengue is endemic in more than 100 countries and is transmitted by the mosquito Aedes aegypti. The use of the symbiotic bacterium Wolbachia has become a potential biocontrol approach against dengue virus for two reasons. First, Wolbachia spreads rapidly through populations by manipulating host reproduction to its advantage. Second, Wolbachia limits viral replication in the mosquito by competing with the virus for essential host resources. Following field release in Cairns, Australia in 2011, the wMel strain of Wolbachia has successfully invaded wild mosquito populations, infecting nearly all individuals. To test whether limited dengue replication in wMel mosquitoes translates to a reduction in dengue transmission potential, we used a non-destructive assay to repeatedly quantify dengue virus in mosquito saliva. We found that wMel significantly delayed the time it took for mosquito saliva to become infectious, reduced the frequency of dengue virus that was expectorated by mosquitoes and lowered the virus titer in mosquito saliva. We also showed that wMel infection suppresses saliva production in mosquitoes that may, in part, explain our findings. The saliva-based nature of the work provides a more accurate assessment of Wolbachia’s ability to limit disease transmission and suggests that Wolbachia may have positive impacts on transmission not only by reducing the number of infectious mosquitoes in a population but also delaying the arrival of virus in the saliva.

8 August 2013 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
YYYixin H. Ye
Yixin H. Ye
MWMegan Woolfit
Megan Woolfit
EREdwige Rancès
Edwige Rancès
SOScott O'Neill
Scott O'Neill
EMElizabeth A. McGraw
Elizabeth A. McGraw
Wolbachia infections confer protection for their insect hosts against a range of pathogens including bacteria, viruses, nematodes and the malaria parasite. A single mechanism that might explain this broad-based pathogen protection is immune priming, in which the presence of the symbiont upregulates the basal immune response, preparing the insect to defend against subsequent pathogen infection. A study that compared natural Wolbachia infections in Drosophila melanogaster with the mosquito vector Aedes aegypti artificially transinfected with the same strains has suggested that innate immune priming may only occur in recent host-Wolbachia associations. This same study also revealed that while immune priming may play a role in viral protection it cannot explain the entirety of the effect. Here we assess whether the level of innate immune priming induced by different Wolbachia strains in A. aegypti is correlated with the degree of protection conferred against bacterial pathogens. We show that Wolbachia strains wMel and wMelPop, currently being tested for field release for dengue biocontrol, differ in their protective abilities. The wMelPop strain provides stronger, more broad-based protection than wMel, and this is likely explained by both the higher induction of immune gene expression and the strain-specific activation of particular genes. We also show that Wolbachia densities themselves decline during pathogen infection, likely as a result of the immune induction. This work shows a correlation between innate immune priming and bacterial protection phenotypes. The ability of the Toll pathway, melanisation and antimicrobial peptides to enhance viral protection or to provide the basis of malaria protection should be further explored in the context of this two-strain comparison. This work raises the questions of whether Wolbachia may improve the ability of wild mosquitoes to survive pathogen infection or alter the natural composition of gut flora, and thus have broader consequences for host fitness. Wolbachia is a commonly occurring bacterium or symbiont that lives inside the cells of insects. Recently, Wolbachia was artificially introduced into the mosquito vector dengue virus that was naturally Wolbachia-free. Wolbachia limits the growth of a range of pathogens transmitted to humans, including viruses, bacteria and parasites inside the mosquito. This “pathogen protection” forms the basis of field trials to determine if releasing Wolbachia into wild mosquito populations could reduce dengue virus incidence in humans. The basis of pathogen protection is not fully understood. Previous work suggests that the symbiont may activate the basal immune response, preparing the insect to defend itself against subsequent pathogen infection. Here we infect mosquitoes harbouring Wolbachia with a range of bacterial pathogens as a means to understand the nature of protection. We show that different Wolbachia strains vary in their ability to limit pathogen growth and that this correlates with the degree to which the Wolbachia activates the host immune response. These findings may assist with Wolbachia strain selection for future open field release and raise the question whether Wolbachia might provide a fitness advantage to mosquitoes in the wild by limiting their death due to bacterial infection.

26 August 2019 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
SFSuzanne A. Ford
Suzanne A. Ford
SAScott L. Allen
Scott L. Allen
JOJohanna R. Ohm
Johanna R. Ohm
LSLeah T. Sigle
Leah T. Sigle
ASAswathy Sebastian
Aswathy Sebastian
EMElizabeth A. McGraw
Elizabeth A. McGraw

1 August 2017 in Current Opinion in Insect Science
Verified
Journal Article
Closed access
GTGerard Terradas
Gerard Terradas
EMElizabeth A McGraw
Elizabeth A McGraw